Suscribirse

Vertebral Coccidioidomycosis: Presentation and Multidisciplinary Management - 16/02/12

Doi : 10.1016/j.amjmed.2011.10.018 
Larissa A. Szeyko, MD a, Mihra S. Taljanovic, MD b, Robert B. Dzioba, MD c, Jennifer L. Rapiejko, MMS d, Rodney D. Adam, MD a,
a Infectious Disease Section, University of Arizona College of Medicine, Tucson, Arizona 
b Department of Radiology, University of Arizona College of Medicine, Tucson, Arizona 
c Spine Surgery, University Medical Center, Tucson, Arizona 
d Rocky Mountain Orthopaedic Associates, Grand Junction, Colo 

Requests for reprints should be addressed to Rodney D. Adam, MD, Infectious Disease Section, University of Arizona College of Medicine, 1501 N. Campbell, Tucson, AZ 85724-5039

Abstract

Background

Vertebral involvement is a severe complication of infection caused by Coccidioides species.

Methods

We conducted a retrospective review of patients diagnosed with vertebral coccidioidomycosis at an academic medical center between 1996 and 2009.

Results

We identified 39 cases of vertebral coccidioidomycosis. Thirty-four patients (79%) were male, and 23 patients (61%) were black. Black patients were overrepresented in comparison with all other patients by a 50-fold odds ratio (95% confidence interval, 26-95). Only 8 patients (20%) were immunocompromised, including 7 who had received systemic steroids. The number of infected vertebrae ranged from 1 to 24; 8 patients (21%) had epidural involvement. All patients received a triazole as part of medical therapy, and 20 patients also received amphotericin B, typically early in the course. Twenty-six patients (67%) required surgery, 18 of whom also required hardware placement. The most common indication for surgery was pain, but 7 patients had neurologic compromise. No patients developed recurrent or refractory infection at the site of surgical debridement, but 6 patients experienced disease relapse after stopping antifungal therapy.

Conclusion

Vertebral infection caused by Coccidioides species requires a multispecialty approach that always includes medical therapy and frequently requires surgical intervention for debridement or stabilization. A favorable outcome can usually be achieved, but discontinuation of medical therapy is associated with a high risk of relapse, which can occur years later.

El texto completo de este artículo está disponible en PDF.

Keywords : African, African-American, Diabetes, Fungal infections, Immunocompromised patient, Osteomyelitis, Spinal fusion, Vertebral


Esquema


 Funding: None.
 Conflict of Interest: None.
 Authorship: All authors had access to the data and played a role in writing this manuscript.


© 2012  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 125 - N° 3

P. 304-314 - mars 2012 Regresar al número
Artículo precedente Artículo precedente
  • Subclinical Thyroid Disease: “Grading” the Risk of Atrial Fibrillation According to Thyrotropin Concentration Is Not Justified
  • Bernard Goichot, Stéphane Vinzio
| Artículo siguiente Artículo siguiente
  • On Being a Chair of Medicine in 2012
  • Arthur M. Feldman

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.